By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Protalex, Inc. 



Albuquerque  New Mexico  87190  U.S.A.
Phone: 505-260-1726 Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
Protalex (PRTX) Issues Letter To Shareholders 6/7/2017 7:49:22 AM
Protalex (PRTX) Significantly Strengthens Global Intellectual Property Portfolio For Proprietary Immunomodulatory Therapeutic 3/13/2017 6:37:42 AM
Protalex (PRTX) Provides Update On U.S. And EU Studies Of PRTX-100 To Treat Immune Thrombocytopenia 2/21/2017 8:33:48 AM
Protalex, Inc. (PRTX) Receives Positive Interim Review From Independent Safety Monitoring Committee In Its European Phase Ib Study Of PRTX-100 To Treat Immune Thrombocytopenia 5/2/2016 8:38:58 AM
Protalex, Inc. (PRTX) Announces Preliminary Findings From Phase I/II Continuation Trial Of PRTX-100 In Active Rheumatoid Arthritis Patients 4/25/2016 10:11:08 AM
Four Small-Cap Biotechs Investors Should Take a Look at 3/15/2016 6:53:30 AM
Protalex, Inc. (PRTX) Receives Positive Interim Review From Independent Safety Monitoring Committee In Its U.S. Phase I/II Study Of PRTX-100 For Immune Thrombocytopenia 2/29/2016 8:23:16 AM
Protalex, Inc. (PRTX) Announces First Patient Dosed In European Phase Ib Study Of PRTX-100 For Immune Thrombocytopenia 1/7/2016 10:51:29 AM
Protalex, Inc. (PRTX) Announces First Patient Dosed In U.S. Phase I/II Study Of PRTX-100 For Immune Thrombocytopenia 11/23/2015 8:32:25 AM
Protalex, Inc. (PRTX) Announces Presentation Of Preclinical Data With PRTX-100 Supporting Treatment Of Immune Thrombocytopenia At The American Society of Hematology 57th Annual Meeting And Exposition 11/11/2015 11:03:12 AM
12345678
//-->